Merck & Company Inc (MRK) support and resistance · P/E 33, rev $16.61B
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
This page maps Merck & Company Inc (MRK) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new MRK 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the MRK quote page for the session range and the stock page for the full model.
Not investment advice.